Home Medicine Negative regulation of CDC42 expression and cell cycle progression by miR-29a in breast cancer
Article Open Access

Negative regulation of CDC42 expression and cell cycle progression by miR-29a in breast cancer

  • Mingliang Zhang , Wei Guo , Jun Qian and Benzhong Wang EMAIL logo
Published/Copyright: March 30, 2016
Download Article (PDF)
Open Medicine
From the journal Open Medicine Volume 11 Issue 1

Abstract

Objective

The inhibitory role of microRNA-29a (miR-29a) has been assessed in breast cancer cells. Herein, we analyze the underlying mechanisms of its role in cell cycle progression in breast cancer cells.

Methods

We applied real-time polymerase chain reaction (PCR) to detect the expression of miR-29 in breast cancer cell lines. Then one of the cell lines, MDA-MB-453, was transfected with mimics of miR-29a. The cell cycle was analyzed by fluorescence-activated cell sorting after staining the cells with propidium iodide. Real-time PCR, luciferase assay and western blot were used together to verify the regulation of the predicted target, cell division cycle 42 (CDC42) by miR-29a.

Results

MiR-29s were decreased in our selected mammary cell lines, among which miR-29a was the dominant isoform. Overexpression of miR-29a caused cell cycle arrest at the G0/G1 phase. We further found that miR-29a could target the expression of CDC42, which is a small GTPase associated with cell cycle progression.

Conclusion

We suggest that miR-29a exerts its tumor suppressor role in breast cancer cells partially by arresting the cell cycle through negative regulation of CDC42.

Keywords: miR-29s; breast cancer; cell cycle; CDC42

1 Introduction

In women, breast cancer (BC) represents the most commonly diagnosed cancer, which is also the second leading cause of cancer-related death after lung cancer [1]. During the last few decades, progress has been made in its prognosis due to efficient and exact early diagnosis, as well as successful radical surgery and adjuvant therapy [2-3]. However, the current determination of prognosis of BC still remains unsatisfactory, and the 5-year survival rate upon the occurrence of metastasis declines to less than 25% [4-6]. Actually, the mechanism underlying the development and progression of BC is far from clearly understood. Hence, gathering more and precise knowledge about its progression would facilitate the generation of novel diagnostic and therapeutic targets. Now there is a large body of evidence showing that a class of small non-coding RNAs, microRNAs (miRNAs), play important parts in BC progression [7-10].

The microRNA-29 (miR-29) family, which is composed of miR-29a, -b and -c, has been shown to be dysregulated and crucially involved in various types of human cancers [11-14], incuding BC [15,16]. Specifically, Wu et al. showed that miR-29a was significantly decreased in different types of BC, and overexpression of miR-29a resulted in cell growth defects. They speculated that the growth inhibitory role of miR-29a might be mediated by its direct targeting B-Myb transcription factor, which is closely associated with tumorigenesis [17]. However, whether other molecular explanations exist, which could further characterize the function of miR-29a in BC cells, has not been well addressed.

Cell division cycle 42 (CDC42) is a well-known member of the Ras homolog (Rho) family. It regulates crucial cellular processes, including cell cycle, and cell cytoskeleton organization [18,19]. The negative regulation of CDC42 by miR-133 has been reported in gastric cancer cells, which correlates with cell proliferation and migration defects [20]. In the current study, we have endeavored to evaluate the role of miR-29a in breast cancer cells and have constructed the relationship of miR-29a with CDC42. Our findings might highlight miR-29a as a novel therapeutic target for BC treatment.

2 Materials and methods

2.1 Cell culture

MCF-10A, MDA-MB-453, MDA-MB-231, T47D and MCF-7 cells were obtained from American Type Culture Collection. Cells were maintained in their proper media and placed in a humidified incubator with 5% CO2 at 37°C.

2.2 Reagents

Control microRNA and miR-29a mimics were purchased from Genepharma. Fetal bovine serum was from GIBCO. The SuperSignal Substrate Western blotting detection system was from Pierce. B-actin antibody and CDC42 antibody were purchased from Santa Cruz. Luciferase Assay Kit was purchased from Promega. Lipofectamine2000 reagent was purchased from Invitrogen.

2.3 Cell transfection

MDA-MB-453 cells were transfected with control or miR-29a mimics by using lipofectamine2000. After 24 hours, cells were used in different experiments. Transfection of MDAMB-453 cells for luciferase assay is described in detail below.

2.4 Quantitative RT-PCR

Total RNA was extracted using Invitrogen Trizol Reagent. The total level of miR-29s or CDC42 was quantified by qRT-PCR by TaKaRa SYBR Green Real-time PCR Master Mix Kit. Fold changes of miRNA and/or mRNA levels were calculated with the 2−ΔΔCt method using the levels of U6B (for miRNA) or gapdh (for mRNA) as the internal controls.

2.5 Cell counting

MDA-MB-453 cells were transfected with control or miR-29a mimics for 48 hours. After that, cells were trypsinzed and seeded into 24-well plates at a density of 6000 cells. Then cells were counted by a blood-cell-counting chamber for the next 4 days. Experiments were repeated at least three times independently.

2.6 Cell cycle assay

The transfected MDA-MB-453 cells were harvested, fixed with cold 70% ethanol overnight at –20°C, and incubated in the dark with RNase (100mg/ml) and propidium iodide (50 mg/ml) for 1 hour at 37°C. A total of 30000 nuclei were examined by flow cytometry.

2.7 Western blotting

Breast cancer cells were lysed with RIPA lysis buffer with a protease inhibitor mixture. After quantification, equal amounts of protein were separated by 10% SDS-PAGE, transferred to Millipore polyvinylidene difluoride membranes, immunoblotted with primary antibodies, and visualized with horseradish-peroxidase-coupled secondary antibodies.

2.8 Dual-luciferase reporter assays

The 3’-untranslated region (3’-UTR) of CDC42 containing the predicted binding site for miR-29 was amplified and cloned into pGL3 vector. Forty-eight hours after transfection, luciferase activity was detected using a dual-luciferase reporter assay system and normalized to Renilla activity.

2.9 miR-29 target prediction

Candidate targets of miR-29 were predicted by miRBase (http://www.mirbase.org/) and TargetScan (http://www.Targetscan.org/).

2.10 Statistical analysis

Statistical analysis was performed using SPSS18.0. Values were expressed as mean ± standard deviation (s.d.). Differences between groups were calculated using the Student’s t-test. P value < 0.05 was considered as statistically significant.

3 Results

3.1 Downregulation of miR-29 in BC cell lines

To examine the relative expression levels of miR-29, including –a, –b and –c, real-time PCR was performed in four human BC cell lines (MDA-MB-453, MD-MB-231, T47D and MCF-7), and in the normal breast epithelium cell line MCF-10A. As shown in Figure 1, all miR-29 showed significantly downregulation in BC cell lines when compared to that of the control MCF-10A cells. Notably, among the miR-29 members, miR-29a represented as the dominant isoform, which showed the most decreased expression in MDA-MB-453 cells. The downregulation of miR-29 in BC cell lines was consistent with the previous findings [17], and suggested that miR-29 might function in a similar way to suppress BC progression.

Figure 1 Relative levels of miR-29 in normal mammary epithelia and breast cancer cells. (A) Comparison of miR-29 isoforms. (B) Relative levels of miR-29 were normalized against the level in MCF-10A cell; U6B was used as an internal control.
Figure 1

Relative levels of miR-29 in normal mammary epithelia and breast cancer cells. (A) Comparison of miR-29 isoforms. (B) Relative levels of miR-29 were normalized against the level in MCF-10A cell; U6B was used as an internal control.

3.2 miR-29a negatively modulate MDA-MB-453 cell growth in vitro

To verify the biological roles, especially the growth inhibitory activities of miR-29a in BC cells, cell growth and cell cycle profile were investigated in MDA-MB-453 cells. As shown in Figure 2A, after synthesized mimics of miR-29a was transfected into the MDA-MB-453 cells, the indicated expression level of miR-29a was significantly elevated. Meanwhile, MDA-MB-453 cells overexpressed with miR-29a displayed slower cell growth rate than control cells (Figure 2B). Importantly, compared to the control cells, overexpression of miR-29a led to cell cycle arrested at the G0/G1 phase (Figure 2C). These results indicated that the growth inhibiting activity of miR-29a could be interpreted by the cell cycle progression defects by these miRNAs, among which miR-29a took the major part in the cellular growth process.

Figure 2 Effects of miR-29a on MDA-MB-453 cell viability. (A) MDA-MB-453 cells were transfected with miR-29a mimics or controls and subjected to qRT-PCR analysis. (B) Effect of miR-29a on MDA-MB-453 cell proliferation was measured by cell counting assay. *: P<0.05. **: P<0.01. (C) Effect of miR-29a on MDA-MB-453 cell cycle was measured by flow cytometry. G0/G1 arrest was increased by miR-29a overexpression. The results represent three independent experiments.
Figure 2

Effects of miR-29a on MDA-MB-453 cell viability. (A) MDA-MB-453 cells were transfected with miR-29a mimics or controls and subjected to qRT-PCR analysis. (B) Effect of miR-29a on MDA-MB-453 cell proliferation was measured by cell counting assay. *: P<0.05. **: P<0.01. (C) Effect of miR-29a on MDA-MB-453 cell cycle was measured by flow cytometry. G0/G1 arrest was increased by miR-29a overexpression. The results represent three independent experiments.

3.3 miR-29a targets CDC42

To probe the potential mechanisms of miR-29 in the BC cell growth, we searched the literature and miRNA database, TargetScan (http://www.targetscan.org/) for potential targets of miR-29. We therefore hypothesized that miR-29 might target CDC42 to inhibit BC cell growth. To confirm our hypothesis, we applied the pMIR-REPORT System. A fragment representing the binding sequences within the 3’-UTR of CDC42 DNA was inserted into the luciferase reporter vector. As shown in Figure 3A, in miR-29a over-expressed groups, the activity of luciferase was significantly inhibited, among which miR-29a exhibited the most decreased luciferase expression. Consistently, western blot confirmed that CDC42 mRNA and protein levels were also decreased in the miR-29a overexpressed cells (Figure 3B). The above findings suggest that miR-29a might all regulate BC cell growth by targeting CDC42.

Figure 3 CDC42 might be a natural target of miR-29s. (A) Dual luciferase assay results. MDA-MB-453 cells were co-transfected with the recombinant firefly-luciferase plasmids containing CDC42 3’-UTR and miR-29a mimics or controls. The firefly luciferase activities were normalized by the Renilla luciferase activities. **: P<0.01. (B) The expression levels of CDC42 proteins determined by Western blot. The expression levels were represented by the band intensities normalized by those of β-actin.
Figure 3

CDC42 might be a natural target of miR-29s. (A) Dual luciferase assay results. MDA-MB-453 cells were co-transfected with the recombinant firefly-luciferase plasmids containing CDC42 3’-UTR and miR-29a mimics or controls. The firefly luciferase activities were normalized by the Renilla luciferase activities. **: P<0.01. (B) The expression levels of CDC42 proteins determined by Western blot. The expression levels were represented by the band intensities normalized by those of β-actin.

4 Discussion

As described previously, miR-29 functions as tumor suppressor in BC progression [15-17]. In other types of human cancers, the roles of miR-29 remain controversial. In clear cell renal cell carcinoma, miR-29 was all downregulated, and restoration of all mature members of miR-29 could inhibit cell proliferation, migration and invasion [21]. However, in a study of pancreatic cancer, miR-29a was found to be increased and could upregulate the expression of pro-inflammatory factors and epithelial-mesenchymal transition (EMT) markers [22]. Hence, the particular roles of miR-29 might be interpreted by its different family members.

In our study, we characterized miR-29a as the dominant isoform of the miR-29 family in our tested BC cells, and we confirmed that miR-29 levels were remarkably decreased in collected BC cell lines. Thereafter, we applied several methods to enrich the functions of miR-29a, and we concluded that miR-29a acted similarly to inhibit cell growth, which might be further explained by the negative modulation of cell cycle progression. A previous study showed that miR-29a could mechanically target tristetraprolin, which is involved in EMT [23], or P42.3, which was also found to be associated with tumorigenicity [24]. Herein, we showed that miR-29a could also target CDC42, and this targeting might be used to explain the regulation of G0/G1 arrest by miR-29a. Still, direct evidence was lacking to prove whether CDC42 could be responsible for the growth inhibitory activity of miR-29a. Furthermore, how miR-29a/CDC42-mediated signaling works to function in BC cells remains to be explained. In addition, although we showed that miR-29a was the dominant and most deregulated form of miR-29 in the indicated BC cell lines, we are still concerned about the similarity of these miR-29 members in regulating cellular biology. More efforts should be made to understand the common and different roles of these miR-29 members.

Taken together, our current findings support the growth-inhibiting function of miR-29a in BC cells through cell cycle regulation, and miR-29a could target CDC42 in a post-transcriptional manner.

Department of Breast Surgery, The First Affiliated Hospital of AnHui Medical University, No.218, JiXi Road, HeiFei City, AnHui province, China

  1. Conflict of interest statement: Authors state no conflict of interest.

References

[1] Sung H, Rosenberg PS, Chen WQ, Hartman M, Lim WY, Chia KS, Wai-Kong Mang O, Chiang CJ, Kang D, Ngan RK, Tse LA, Anderson WF, Yang XR: Female breast cancer incidence among Asian and Western populations: more similar than expected. J Natl Cancer Inst 2015; 107(7): pii: djv10710.1093/jnci/djv107Search in Google Scholar PubMed PubMed Central

[2] Gerasimova E, Audit B, Roux SG, Khalil A, Gileva O, Argoul F, Naimark O, Arneodo A: Wavelet-based multifractal analysis of dynamic infrared thermograms to assist in early breast cancer diagnosis. Front Physiol 2014; 5:17610.3389/fphys.2014.00176Search in Google Scholar PubMed PubMed Central

[3] Chan A, Shannon C, de Boer R, Baron-Hay S, Redfern A, Bauwens A, Craft P, Webb S, Townsend A, Kotasek D: Phase II, open-label trial of lapatinib and vinorelbine in women with previously treated HER2-positive metastatic breast cancer. Asia Pac J Clin Oncol 2014; 10(4):368-37510.1111/ajco.12292Search in Google Scholar PubMed

[4] Siegel R, Naishadham D, Jemal A: Cancer statistics. CA Cancer J Clin 2013; 63(1):11-3010.3322/caac.21166Search in Google Scholar PubMed

[5] Jang GB, Kim JY, Cho SD, Park KS, Jung JY, Lee HY, Hong IS, Nam JS: Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype. Sci Rep 2015; 5:1246510.1038/srep12465Search in Google Scholar PubMed PubMed Central

[6] Printz C: Low breast density linked to poor breast cancer prognosis. Cancer 2015; 121(15):247910.1002/cncr.29558Search in Google Scholar

[7] Bertoli G, Cava C, Castiglioni I: MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer. Theranostics 2015;5(10):1122-114310.7150/thno.11543Search in Google Scholar PubMed PubMed Central

[8] Takahashi RU, Miyazaki H, Ochiya T: The Roles of MicroRNAs in Breast Cancer. Cancers (Basel) 2015; 7(2):598-61610.3390/cancers7020598Search in Google Scholar PubMed PubMed Central

[9] Zhang W, Liu J, Wang G: The role of microRNAs in human breast cancer progression. Tumour Biol 2014; 35(7):6235-624410.1007/s13277-014-2202-8Search in Google Scholar PubMed

[10] Shah NR, Chen H: MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment. World J Clin Oncol 2014; 5(2):48-6010.5306/wjco.v5.i2.48Search in Google Scholar PubMed PubMed Central

[11] Amodio N, Rossi M, Raimondi L, Pitari MR, Botta C, Tagliaferri P, Tassone P: miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies. Oncotarget 2015; 6(15):12837-1286110.18632/oncotarget.3805Search in Google Scholar PubMed PubMed Central

[12] Jiang H, Zhang G, Wu JH, Jiang CP: Diverse roles of miR-29 in cancer (review). Oncol Rep 2014; 31(4):1509-151610.3892/or.2014.3036Search in Google Scholar PubMed

[13] Wang Y, Zhang X, Li H, Yu J, Ren X: The role of miRNA-29 family in cancer. Eur J Cell Biol 2013; 92(3):123-12810.1016/j.ejcb.2012.11.004Search in Google Scholar PubMed

[14] Schmitt MJ, Margue C, Behrmann I, Kreis S: MiRNA-29: a microRNA family with tumor-suppressing and immune-modulating properties. Curr Mol Med 2013; 13(4):572-58510.2174/1566524011313040009Search in Google Scholar PubMed

[15] Rostas JW 3rd, Pruitt HC, Metge BJ, Mitra A, Bailey SK, Bae S, Singh KP, Devine DJ, Dyess DL, Richards WO, Tucker JA, Shevde LA, Samant RS: microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer. Mol Cancer 2014; 13:20010.1186/1476-4598-13-200Search in Google Scholar PubMed PubMed Central

[16] Cittelly DM, Finlay-Schultz J, Howe EN, Spoelstra NS, Axlund SD, Hendricks P, Jacobsen BM, Sartorius CA, Richer JK: Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. Oncogene 2013; 32(20):2555-256410.1038/onc.2012.275Search in Google Scholar PubMed PubMed Central

[17] Wu Z, Huang X, Huang X, Zou Q, Guo Y: The inhibitory role of Mir-29 in growth of breast cancer cells. J Exp Clin Cancer Res. 2013 Dec 1;32:9810.1186/1756-9966-32-98Search in Google Scholar PubMed PubMed Central

[18] Cerione RA: Cdc42: new roads to travel. Trends Cell Biol 2004; Mar;14(3):127-13210.1016/j.tcb.2004.01.008Search in Google Scholar PubMed

[19] Arias-Romero LE, Chernoff J: Targeting Cdc42 in cancer. Expert Opin Ther Targets 2013; 17(11):1263-127310.1517/14728222.2013.828037Search in Google Scholar PubMed PubMed Central

[20] Cheng Z, Liu F, Wang G, Li Y, Zhang H, Li F: miR-133 is a key negative regulator of CDC42-PAK pathway in gastric cancer. Cell Signal 2014; 26(12):2667-267310.1016/j.cellsig.2014.08.012Search in Google Scholar PubMed

[21] Nishikawa R, Chiyomaru T, Enokida H, Inoguchi S, Ishihara T, Matsushita R, Goto Y, Fukumoto I, Nakagawa M, Seki N: Tumour-suppressive microRNA-29s directly regulate LOXL2 expression and inhibit cancer cell migration and invasion in renal cell carcinoma. FEBS Lett 2015; 589(16):2136-214510.1016/j.febslet.2015.06.005Search in Google Scholar PubMed

[22] Sun XJ, Liu BY, Yan S, Jiang TH, Cheng HQ, Jiang HS, Cao Y, Mao AW: MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin. Cell Physiol Biochem 2015;37(2):707-71810.1159/000430389Search in Google Scholar PubMed

[23] Gebeshuber CA, Zatloukal K, Martinez J: miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep 2009; 10(4):400-40510.1038/embor.2009.9Search in Google Scholar PubMed PubMed Central

[24] Cui Y, Su WY, Xing J, Wang YC, Wang P, Chen XY, Shen ZY, Cao H, Lu YY, Fang JY: MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer. PloS One 2011; 6(10):e2587210.1371/journal.pone.0025872Search in Google Scholar PubMed PubMed Central

Received: 2015-10-20
Accepted: 2016-1-5
Published Online: 2016-3-30
Published in Print: 2016-1-1

© 2016 Mingliang Zhang et al.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Articles in the same Issue

  1. Research Article
  2. The possible molecular regulation mechanism of CIK cells inhibiting the proliferation of Human Lung Adenocarcinoma NCL-H157 Cells
  3. Case Report
  4. Urethral stone of unexpected size: case report and short literature review
  5. Case Report
  6. Complete remission through icotinib treatment in Non-small cell lung cancer epidermal growth factor receptor mutation patient with brain metastasis: A case report
  7. Research Article
  8. FPL tendon thickness, tremor and hand functions in Parkinson’s disease
  9. Research Article
  10. Diagnostic value of circulating tumor cells in cerebrospinal fluid
  11. Research Article
  12. A meta-analysis of neuroprotective effect for traditional Chinese medicine (TCM) in the treatment of glaucoma
  13. Research Article
  14. MiR-218 increases sensitivity to cisplatin in esophageal cancer cells via targeting survivin expression
  15. Research Article
  16. Association of HOTAIR expression with PI3K/Akt pathway activation in adenocarcinoma of esophagogastric junction
  17. Research Article
  18. The role of interleukin genes in the course of depression
  19. Case Report
  20. A rare case of primary pulmonary diffuse large B cell lymphoma with CD5 positive expression
  21. Research Article
  22. DWI and SPARCC scoring assess curative effect of early ankylosing spondylitis
  23. Research Article
  24. The diagnostic value of serum CEA, NSE and MMP-9 for on-small cell lung cancer
  25. Case Report
  26. Dysphonia – the single symptom of rifampicin resistant laryngeal tuberculosis
  27. Review Article
  28. Development of epidermal growth factor receptor tyrosine kinase inhibitors against EGFR T790M. Mutation in non small-cell lung carcinoma
  29. Research Article
  30. Negative regulation of CDC42 expression and cell cycle progression by miR-29a in breast cancer
  31. Research Article
  32. Expression analysis of the TGF-β/SMAD target genes in adenocarcinoma of esophagogastric junction
  33. Research Article
  34. Blood cells in thyroid cancer patients: a possible influence of apoptosis
  35. Research Article
  36. Detected EGFR mutation in cerebrospinal fluid of lung adenocarcinoma patients with meningeal metastasis
  37. Mini-review
  38. Pathogenesis-oriented approaches for the management of corticosteroid-resistant or relapsedprimary immune thrombocytopenia
  39. Research Article
  40. GSTP1 A>G polymorphism and chemosensitivity of osteosarcoma: A meta-analysis
  41. Research Article
  42. A meta-analysis of adiponectin gene rs22411766 T>G polymorphism and ischemic stroke susceptibility
  43. Research Article
  44. The diagnosis and pathological value of combined detection of HE4 and CA125 for patients with ovarian cancer
  45. Research Article
  46. SOX7 inhibits tumor progression of glioblastoma and is regulated by miRNA-24
  47. Research Article
  48. Sevoflurane affects evoked electromyography monitoring in cerebral palsy
  49. Case Report
  50. A case report of hereditary spherocytosis with concomitant chronic myelocytic leukemia
  51. Case Report
  52. A case of giant saphenous vein graft aneurysm followed serially after coronary artery bypass surgery
  53. Research Article
  54. LncRNA TUG1 is upregulated and promotes cell proliferation in osteosarcoma
  55. Review Article
  56. Meningioma recurrence
  57. Case Report
  58. Endobronchial amyloidosis mimicking bronchial asthma: a case report and review of the literature
  59. Case Report
  60. A confusing case report of pulmonary langerhans cell histiocytosis and literature review
  61. Research Article
  62. Effect of hesperetin on chaperone activity in selenite-induced cataract
  63. Research Article
  64. Clinical value of self-assessment risk of osteoporosis in Chinese
  65. Research Article
  66. Correlation analysis of VHL and Jade-1 gene expression in human renal cell carcinoma
  67. Research Article
  68. Is acute appendicitis still misdiagnosed?
  69. Retraction
  70. Retraction of: application of food-specific IgG antibody detection in allergy dermatosis
  71. Review Article
  72. Platelet Rich Plasma: a short overview of certain bioactive components
  73. Research Article
  74. Correlation between CTLA-4 gene rs221775A>G single nucleotide polymorphism and multiple sclerosis susceptibility. A meta-analysis
  75. Review Article
  76. Standards of anesthesiology practice during neuroradiological interventions
  77. Research Article
  78. Expression and clinical significance of LXRα and SREBP-1c in placentas of preeclampsia
  79. Letter to the Editor
  80. ARDS diagnosed by SpO2/FiO2 ratio compared with PaO2/FiO2 ratio: the role as a diagnostic tool for early enrolment into clinical trials
  81. Research Article
  82. Impact of sensory integration training on balance among stroke patients: sensory integration training on balance among stroke patients
  83. Review Article
  84. MicroRNAs as regulatory elements in psoriasis
  85. Review Article
  86. Influenza A(H1N1)pdm09 and postpandemic influenza in Lithuania
  87. Review Article
  88. Garengeot’s hernia: two case reports with CT diagnosis and literature review
  89. Research Article
  90. Concept of experimental preparation for treating dentin hypersensitivity
  91. Research Article
  92. Hydrogen water reduces NSE, IL-6, and TNF-α levels in hypoxic-ischemic encephalopathy
  93. Research Article
  94. Xanthogranuloma of the sellar region diagnosed by frozen section
  95. Case Report
  96. Laparoscopic antegrade cholecystectomy: a standard procedure?
  97. Case Report
  98. Maxillary fibrous dysplasia associated with McCune-Albright syndrome. A case study
  99. Regular Article
  100. Sialoendoscopy, sialography, and ultrasound: a comparison of diagnostic methods
  101. Research Article
  102. Antibody Response to Live Attenuated Vaccines in Adults in Japan
  103. Conference article
  104. Excellence and safety in surgery require excellent and safe tutoring
  105. Conference article
  106. Suggestions on how to make suboptimal kidney transplantation an ethically viable option
  107. Regular Article
  108. Ectopic pregnancy treatment by combination therapy
  109. Conference article
  110. Use of a simplified consent form to facilitate patient understanding of informed consent for laparoscopic cholecystectomy
  111. Regular Article
  112. Cusum analysis for learning curve of videothoracoscopic lobectomy
  113. Regular Article
  114. A meta-analysis of association between glutathione S-transferase M1 gene polymorphism and Parkinson’s disease susceptibility
  115. Conference article
  116. Plastination: ethical and medico-legal considerations
  117. Regular Article
  118. Investigation and control of a suspected nosocomial outbreak of pan-drug resistant Acinetobacter baumannii in an intensive care unit
  119. Regular Article
  120. Multifactorial analysis of fatigue scale among nurses in Poland
  121. Regular Article
  122. Smoking cessation for free: outcomes of a study of three Romanian clinics
  123. Regular Article
  124. Clinical efficacy and safety of tripterygium glycosides in treatment of stage IV diabetic nephropathy: A meta-analysis
  125. Special Issue on Italian Society for the Study of Vascular Anomalies
  126. Prevention and treatment of peritoneal adhesions in patients affected by vascular diseases following surgery: a review of the literature
  127. Special Issue on Italian Society for the Study of Vascular Anomalies
  128. Surgical treatment of recidivist lymphedema
  129. Special Issue on Italian Society for the Study of Vascular Anomalies
  130. CT and MR imaging of the thoracic aorta
  131. Special Issue on Italian Society for the Study of Vascular Anomalies
  132. Role of FDG-PET scan in staging of pulmonary epithelioid hemangioendothelioma
  133. Special Issue on Italian Society for the Study of Vascular Anomalies
  134. Sternal reconstruction by extracellular matrix: a rare case of phaces syndrome
  135. Special Issue on Italian Society for the Study of Vascular Anomalies
  136. Prenatal diagnosis, 3-D virtual rendering and lung sparing surgery by ligasure device in a baby with “CCAM and intralobar pulmonary sequestration”
  137. Special Issue on Italian Society for the Study of Vascular Anomalies
  138. Serum levels of inhibin B in adolescents after varicocelelectomy: A long term follow up
  139. Special Issue on Italian Society for the Study of Vascular Anomalies
  140. Our experience in the treatment of Malignant Fibrous Hystiocytoma of the larynx: clinical diagnosis, therapeutic approach and review of literature
  141. Special Issue on Italian Society for the Study of Vascular Anomalies
  142. Delayed recurrent nerve paralysis following post-traumatic aortic pseudoaneurysm
  143. Special Issue on Italian Society for the Study of Vascular Anomalies
  144. Integrated therapeutic approach to giant solitary fibrous tumor of the pleura: report of a case and review of the literature
  145. Special Issue on Italian Society for the Study of Vascular Anomalies
  146. Celiac axis compression syndrome: laparoscopic approach in a strange case of chronic abdominal pain in 71 years old man
  147. Special Issue on Italian Society for the Study of Vascular Anomalies
  148. A rare case of persistent hypoglossal artery associated with contralateral proximal subclavian stenosis
  149. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  150. Contralateral risk reducing mastectomy in Non-BRCA-Mutated patients
  151. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  152. Professional dental and oral surgery liability in Italy: a comparative analysis of the insurance products offered to health workers
  153. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  154. Informed consent in robotic surgery: quality of information and patient perception
  155. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  156. Malfunctions of robotic system in surgery: role and responsibility of surgeon in legal point of view
  157. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  158. Medicolegal implications of surgical errors and complications in neck surgery: A review based on the Italian current legislation
  159. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  160. Iatrogenic splenic injury: review of the literature and medico-legal issues
  161. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  162. Donation of the body for scientific purposes in Italy: ethical and medico-legal considerations
  163. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  164. Cosmetic surgery: medicolegal considerations
  165. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  166. Voluntary termination of pregnancy (medical or surgical abortion): forensic medicine issues
  167. Review Article
  168. Role of Laparoscopic Splenectomy in Elderly Immune Thrombocytopenia
  169. Review Article
  170. Endoscopic diagnosis and treatment of neuroendocrine tumors of the digestive system
  171. Review Article
  172. Efficacy and safety of splenectomy in adult autoimmune hemolytic anemia
  173. Research Article
  174. Relationship between gastroesophageal reflux disease and Ph nose and salivary: proposal of a simple method outpatient in patients adults
  175. Case Report
  176. Idiopathic pleural panniculitis with recurrent pleural effusion not associated with Weber-Christian disease
  177. Research Article
  178. Morbid Obesity: treatment with Bioenterics Intragastric Balloon (BIB), psychological and nursing care: our experience
  179. Research Article
  180. Learning curve for endorectal ultrasound in young and elderly: lights and shades
  181. Case Report
  182. Uncommon primary hydatid cyst occupying the adrenal gland space, treated with laparoscopic surgical approach in an old patient
  183. Research Article
  184. Distraction techniques for face and smile aesthetic preventing ageing decay
  185. Research Article
  186. Preoperative high-intensity training in frail old patients undergoing pulmonary resection for NSCLC
  187. Review Article
  188. Descending necrotizing mediastinitis in the elderly patients
  189. Research Article
  190. Prophylactic GSV surgery in elderly candidates for hip or knee arthroplasty
  191. Research Article
  192. Diagnostic yield and safety of C-TBNA in elderly patients with lung cancer
  193. Research Article
  194. The learning curve of laparoscopic holecystectomy in general surgery resident training: old age of the patient may be a risk factor?
  195. Research Article
  196. Self-gripping mesh versus fibrin glue fixation in laparoscopic inguinal hernia repair: a randomized prospective clinical trial in young and elderly patients
  197. Research Article
  198. Anal sphincter dysfunction in multiple sclerosis: an observation manometric study
https://doi.org/10.1515/med-2016-0015
Keywords for this article
miR-29s; breast cancer; cell cycle; CDC42
Creative Commons
BY-NC-ND 3.0

Articles in the same Issue

  1. Research Article
  2. The possible molecular regulation mechanism of CIK cells inhibiting the proliferation of Human Lung Adenocarcinoma NCL-H157 Cells
  3. Case Report
  4. Urethral stone of unexpected size: case report and short literature review
  5. Case Report
  6. Complete remission through icotinib treatment in Non-small cell lung cancer epidermal growth factor receptor mutation patient with brain metastasis: A case report
  7. Research Article
  8. FPL tendon thickness, tremor and hand functions in Parkinson’s disease
  9. Research Article
  10. Diagnostic value of circulating tumor cells in cerebrospinal fluid
  11. Research Article
  12. A meta-analysis of neuroprotective effect for traditional Chinese medicine (TCM) in the treatment of glaucoma
  13. Research Article
  14. MiR-218 increases sensitivity to cisplatin in esophageal cancer cells via targeting survivin expression
  15. Research Article
  16. Association of HOTAIR expression with PI3K/Akt pathway activation in adenocarcinoma of esophagogastric junction
  17. Research Article
  18. The role of interleukin genes in the course of depression
  19. Case Report
  20. A rare case of primary pulmonary diffuse large B cell lymphoma with CD5 positive expression
  21. Research Article
  22. DWI and SPARCC scoring assess curative effect of early ankylosing spondylitis
  23. Research Article
  24. The diagnostic value of serum CEA, NSE and MMP-9 for on-small cell lung cancer
  25. Case Report
  26. Dysphonia – the single symptom of rifampicin resistant laryngeal tuberculosis
  27. Review Article
  28. Development of epidermal growth factor receptor tyrosine kinase inhibitors against EGFR T790M. Mutation in non small-cell lung carcinoma
  29. Research Article
  30. Negative regulation of CDC42 expression and cell cycle progression by miR-29a in breast cancer
  31. Research Article
  32. Expression analysis of the TGF-β/SMAD target genes in adenocarcinoma of esophagogastric junction
  33. Research Article
  34. Blood cells in thyroid cancer patients: a possible influence of apoptosis
  35. Research Article
  36. Detected EGFR mutation in cerebrospinal fluid of lung adenocarcinoma patients with meningeal metastasis
  37. Mini-review
  38. Pathogenesis-oriented approaches for the management of corticosteroid-resistant or relapsedprimary immune thrombocytopenia
  39. Research Article
  40. GSTP1 A>G polymorphism and chemosensitivity of osteosarcoma: A meta-analysis
  41. Research Article
  42. A meta-analysis of adiponectin gene rs22411766 T>G polymorphism and ischemic stroke susceptibility
  43. Research Article
  44. The diagnosis and pathological value of combined detection of HE4 and CA125 for patients with ovarian cancer
  45. Research Article
  46. SOX7 inhibits tumor progression of glioblastoma and is regulated by miRNA-24
  47. Research Article
  48. Sevoflurane affects evoked electromyography monitoring in cerebral palsy
  49. Case Report
  50. A case report of hereditary spherocytosis with concomitant chronic myelocytic leukemia
  51. Case Report
  52. A case of giant saphenous vein graft aneurysm followed serially after coronary artery bypass surgery
  53. Research Article
  54. LncRNA TUG1 is upregulated and promotes cell proliferation in osteosarcoma
  55. Review Article
  56. Meningioma recurrence
  57. Case Report
  58. Endobronchial amyloidosis mimicking bronchial asthma: a case report and review of the literature
  59. Case Report
  60. A confusing case report of pulmonary langerhans cell histiocytosis and literature review
  61. Research Article
  62. Effect of hesperetin on chaperone activity in selenite-induced cataract
  63. Research Article
  64. Clinical value of self-assessment risk of osteoporosis in Chinese
  65. Research Article
  66. Correlation analysis of VHL and Jade-1 gene expression in human renal cell carcinoma
  67. Research Article
  68. Is acute appendicitis still misdiagnosed?
  69. Retraction
  70. Retraction of: application of food-specific IgG antibody detection in allergy dermatosis
  71. Review Article
  72. Platelet Rich Plasma: a short overview of certain bioactive components
  73. Research Article
  74. Correlation between CTLA-4 gene rs221775A>G single nucleotide polymorphism and multiple sclerosis susceptibility. A meta-analysis
  75. Review Article
  76. Standards of anesthesiology practice during neuroradiological interventions
  77. Research Article
  78. Expression and clinical significance of LXRα and SREBP-1c in placentas of preeclampsia
  79. Letter to the Editor
  80. ARDS diagnosed by SpO2/FiO2 ratio compared with PaO2/FiO2 ratio: the role as a diagnostic tool for early enrolment into clinical trials
  81. Research Article
  82. Impact of sensory integration training on balance among stroke patients: sensory integration training on balance among stroke patients
  83. Review Article
  84. MicroRNAs as regulatory elements in psoriasis
  85. Review Article
  86. Influenza A(H1N1)pdm09 and postpandemic influenza in Lithuania
  87. Review Article
  88. Garengeot’s hernia: two case reports with CT diagnosis and literature review
  89. Research Article
  90. Concept of experimental preparation for treating dentin hypersensitivity
  91. Research Article
  92. Hydrogen water reduces NSE, IL-6, and TNF-α levels in hypoxic-ischemic encephalopathy
  93. Research Article
  94. Xanthogranuloma of the sellar region diagnosed by frozen section
  95. Case Report
  96. Laparoscopic antegrade cholecystectomy: a standard procedure?
  97. Case Report
  98. Maxillary fibrous dysplasia associated with McCune-Albright syndrome. A case study
  99. Regular Article
  100. Sialoendoscopy, sialography, and ultrasound: a comparison of diagnostic methods
  101. Research Article
  102. Antibody Response to Live Attenuated Vaccines in Adults in Japan
  103. Conference article
  104. Excellence and safety in surgery require excellent and safe tutoring
  105. Conference article
  106. Suggestions on how to make suboptimal kidney transplantation an ethically viable option
  107. Regular Article
  108. Ectopic pregnancy treatment by combination therapy
  109. Conference article
  110. Use of a simplified consent form to facilitate patient understanding of informed consent for laparoscopic cholecystectomy
  111. Regular Article
  112. Cusum analysis for learning curve of videothoracoscopic lobectomy
  113. Regular Article
  114. A meta-analysis of association between glutathione S-transferase M1 gene polymorphism and Parkinson’s disease susceptibility
  115. Conference article
  116. Plastination: ethical and medico-legal considerations
  117. Regular Article
  118. Investigation and control of a suspected nosocomial outbreak of pan-drug resistant Acinetobacter baumannii in an intensive care unit
  119. Regular Article
  120. Multifactorial analysis of fatigue scale among nurses in Poland
  121. Regular Article
  122. Smoking cessation for free: outcomes of a study of three Romanian clinics
  123. Regular Article
  124. Clinical efficacy and safety of tripterygium glycosides in treatment of stage IV diabetic nephropathy: A meta-analysis
  125. Special Issue on Italian Society for the Study of Vascular Anomalies
  126. Prevention and treatment of peritoneal adhesions in patients affected by vascular diseases following surgery: a review of the literature
  127. Special Issue on Italian Society for the Study of Vascular Anomalies
  128. Surgical treatment of recidivist lymphedema
  129. Special Issue on Italian Society for the Study of Vascular Anomalies
  130. CT and MR imaging of the thoracic aorta
  131. Special Issue on Italian Society for the Study of Vascular Anomalies
  132. Role of FDG-PET scan in staging of pulmonary epithelioid hemangioendothelioma
  133. Special Issue on Italian Society for the Study of Vascular Anomalies
  134. Sternal reconstruction by extracellular matrix: a rare case of phaces syndrome
  135. Special Issue on Italian Society for the Study of Vascular Anomalies
  136. Prenatal diagnosis, 3-D virtual rendering and lung sparing surgery by ligasure device in a baby with “CCAM and intralobar pulmonary sequestration”
  137. Special Issue on Italian Society for the Study of Vascular Anomalies
  138. Serum levels of inhibin B in adolescents after varicocelelectomy: A long term follow up
  139. Special Issue on Italian Society for the Study of Vascular Anomalies
  140. Our experience in the treatment of Malignant Fibrous Hystiocytoma of the larynx: clinical diagnosis, therapeutic approach and review of literature
  141. Special Issue on Italian Society for the Study of Vascular Anomalies
  142. Delayed recurrent nerve paralysis following post-traumatic aortic pseudoaneurysm
  143. Special Issue on Italian Society for the Study of Vascular Anomalies
  144. Integrated therapeutic approach to giant solitary fibrous tumor of the pleura: report of a case and review of the literature
  145. Special Issue on Italian Society for the Study of Vascular Anomalies
  146. Celiac axis compression syndrome: laparoscopic approach in a strange case of chronic abdominal pain in 71 years old man
  147. Special Issue on Italian Society for the Study of Vascular Anomalies
  148. A rare case of persistent hypoglossal artery associated with contralateral proximal subclavian stenosis
  149. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  150. Contralateral risk reducing mastectomy in Non-BRCA-Mutated patients
  151. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  152. Professional dental and oral surgery liability in Italy: a comparative analysis of the insurance products offered to health workers
  153. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  154. Informed consent in robotic surgery: quality of information and patient perception
  155. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  156. Malfunctions of robotic system in surgery: role and responsibility of surgeon in legal point of view
  157. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  158. Medicolegal implications of surgical errors and complications in neck surgery: A review based on the Italian current legislation
  159. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  160. Iatrogenic splenic injury: review of the literature and medico-legal issues
  161. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  162. Donation of the body for scientific purposes in Italy: ethical and medico-legal considerations
  163. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  164. Cosmetic surgery: medicolegal considerations
  165. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  166. Voluntary termination of pregnancy (medical or surgical abortion): forensic medicine issues
  167. Review Article
  168. Role of Laparoscopic Splenectomy in Elderly Immune Thrombocytopenia
  169. Review Article
  170. Endoscopic diagnosis and treatment of neuroendocrine tumors of the digestive system
  171. Review Article
  172. Efficacy and safety of splenectomy in adult autoimmune hemolytic anemia
  173. Research Article
  174. Relationship between gastroesophageal reflux disease and Ph nose and salivary: proposal of a simple method outpatient in patients adults
  175. Case Report
  176. Idiopathic pleural panniculitis with recurrent pleural effusion not associated with Weber-Christian disease
  177. Research Article
  178. Morbid Obesity: treatment with Bioenterics Intragastric Balloon (BIB), psychological and nursing care: our experience
  179. Research Article
  180. Learning curve for endorectal ultrasound in young and elderly: lights and shades
  181. Case Report
  182. Uncommon primary hydatid cyst occupying the adrenal gland space, treated with laparoscopic surgical approach in an old patient
  183. Research Article
  184. Distraction techniques for face and smile aesthetic preventing ageing decay
  185. Research Article
  186. Preoperative high-intensity training in frail old patients undergoing pulmonary resection for NSCLC
  187. Review Article
  188. Descending necrotizing mediastinitis in the elderly patients
  189. Research Article
  190. Prophylactic GSV surgery in elderly candidates for hip or knee arthroplasty
  191. Research Article
  192. Diagnostic yield and safety of C-TBNA in elderly patients with lung cancer
  193. Research Article
  194. The learning curve of laparoscopic holecystectomy in general surgery resident training: old age of the patient may be a risk factor?
  195. Research Article
  196. Self-gripping mesh versus fibrin glue fixation in laparoscopic inguinal hernia repair: a randomized prospective clinical trial in young and elderly patients
  197. Research Article
  198. Anal sphincter dysfunction in multiple sclerosis: an observation manometric study
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2026 De Gruyter Brill
Downloaded on 15.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/med-2016-0015/html
Scroll to top button